Abstract. Inflammatory changes in the gastric mucosa are commonly observed in Japanese patients with functional dyspepsia (FD). However, detailed data regarding the relationship between the genetic regulatory factors of inflammation and FD are not available. We investigated the associations between FD and genetic polymorphisms of molecules associated with inflammation or immune response (IL-17A, -17F and MIF). The study was performed with 278 subjects (188 with no upper abdominal symptoms and 90 with FD according to the Roma III criteria). We employed the PCR-SSCP (multiplex PCR for IL-17A and -17F) method to detect the gene polymorphisms. Overall, the polymorphisms of the IL-17A, -17F and MIF genes were not correlated with the susceptibility to FD. However, the MIF -173C allele carrier had a significantly increased risk for the development of epigastric pain syndrome (EPS) of FD (OR, 2.12; 95% CI, 1.00-4.49; p=0.0497). In Helicobacter pylori (H. pylori)-infected cases, the number of IL-17F 7488T alleles was positively correlated with the development of EPS (OR, 11.3; 95% CI, 1.23-103.2; p=0.032), while the IL-17F T/T homozygote and the MIF -173C carrier had an increased risk for EPS (OR, 10.4; 95% CI, p=0.036 and OR, 3.66; 95% CI, p=0.024, respectively). In addition, a significant interaction between the IL-17F 7488 polymorphism and H. pylori infection was shown to increase the activity and inflammation scores (p=0.043 and 0.042, respectively). There were no significant associations between the IL-17A polymorphism and FD. Our results provide the first evidence that the IL-17F and MIF gene polymorphisms are significantly associated with the development of FD, particularly EPS, a subgroup of FD, in H. pylori-infected subjects. The genetic polymorphisms of inflammation or immune response-related molecules are involved in the development of one of the FD subgroups via H. pylori-induced gastric inflammation.
Introduction
Functional dyspepsia (FD) is a common clinical syndrome characterized by the presence of recurrent or chronic upper abdominal symptoms, such as epigastric pain, early satiety, and fullness, without anatomical or biochemical abnormalities identifiable by conventional diagnostic tests, including upper gastrointestinal endoscopy (1). Talley et al have shown that up to 25% of the population experience these symptoms (2) . FD is a heterogeneous condition indicated by a variety of different pathophysiologic mechanisms which have been demonstrated in this disorder (3), thus, FD does not have a well-established pathophysiology. Gastrointestinal motor abnormalities (4), altered visceral sensation (5) and psychosocial factors (6) have been reported to play essential roles in the pathophysiology of FD. Locke et al reported familial clustering of FD (7) . In addition, it was reported that the Gprotein ß3 subunit gene polymorphism is associated with FD (8, 9) . These facts suggest that genetic factors may play a significant role in the development of FD.
On the other hand, Helicobacter pylori (H. pylori) infection is a powerful pathogenic factor, and many studies have revealed a strong association between infection of this organism and gastric disorders. H. pylori infection usually leads to persistent colonization and chronic gastric inflammation. According to the Roma III criteria (10) , H. pyloriinfected patients, who had some chronic or recurrent upper abdominal symptoms with neither ulceration nor erosion in the gastroduodenal mucosa by gastrointestinal endoscopy, were diagnosed with FD. That is, there is a possibility that one of the FD subgroups is associated with gastric mucosal inflammation, although adult FD patients frequently have motility abnormalities of the stomach and the upper small bowel including antral hypomotility and delayed gastric emptying (11) (12) (13) .
Interleukin-17 (IL-17) is a relatively newly described cytokine which bridges the adaptive and innate immune systems. IL-17 family members belong to a distinct category of cytokines and play a role in coordinating local tissue inflammation by inducing the release of proinflammatory and neutrophil-mobilizing cytokines (14) . In addition, IL-17A and -17F share similar functions in terms of their ability to induce chemokines that are important in neutrophil recruitment and activation. Recently, Kawaguchi et al reported that the IL-17F 7488T/C (rs763780), which causes a His-to-Arg substitution at amino acid 161 (H161R) variant, influences the risk of asthma and is a natural IL-17F antagonist in the known polymorphisms of the IL-17 gene (15) . Macrophage migration inhibitory factor (MIF) was originally identified as an activity isolated from T lymphocytes which was capable of inhibiting the random migration of macrophages (16) . MIF contributes toward an excessive inflammatory response both directly and via an induction of proinflammatory cytokine secretion (17) . Polymorphisms with potential functional relevance have been identified in the MIF gene promoter; a SNP at position -173 (G to C) (18) and a tetranucleotide CATT repeat beginning at nucleotide position -794 (19) were found to be associated with altered levels of MIF gene transcription in vitro. Important roles of both IL-17 and MIF in the inflammatory response to H. pylori infection have been demonstrated (20, 21) . Therefore, we hypothesized the possibility that the functional polymorphisms of IL-17 and MIF genes may be associated with the development and the pathophysiological features of FD.
In the present study, we investigated the association between the polymorphisms of IL-17A (G-197A, rs2275913), -17F (7488T/C, rs763780), and MIF (G-173C and -794 tetranucleotide repeats) and FD diagnosed according to the Roma III criteria.
Materials and methods
Clinical samples. We randomly selected 300 samples from our stocked DNA obtained in 2006. Two hundred subjects, enrolled at the Endoscopy Center of Fujita Health University Hospital, had previously undergone upper gastrointestinal endoscopy to check for gastric cancer followed by a barium X-ray examination as a health check or for the complaint of abdominal discomfort. One hundred subjects were healthy volunteers with no abdominal symptoms. For certain subjects, the severity of gastric inflammation was assessed according to the updated Sydney system using biopsy specimens taken from the antral mucosa by a pathologist who had no access to any clinical information. Subjects who had significant upper gastrointestinal findings such as peptic ulcer diseases, reflex esophagitis and malignancies were excluded from this study. Patients with severe systemic diseases and malignancies in other organs, or who had received non-steroidal antiinflammatory drugs, antibiotics and H. pylori eradication therapy were also excluded.
According to the Roma III criteria, 90 dyspeptic patients were identified as having a primary complaint of either continuous or intermittent dyspepsia for 3 months, onset at least 6 months before, predominantly located in the upper abdomen. In 90 dyspeptic patients, 46 and 39 patients were diagnosed with epigastric pain syndrome (EPS) and postprandial syndrome (PDS), respectively. Subjects who had no dyspeptic symptoms within the last 12 months were considered as non-dyspepsia subjects. Finally, the study population comprised 278 subjects whose DNA was clearly analyzed, including 94 healthy volunteers.
The Ethics Committee of the Fujita Health University School of Medicine approved the protocol, and written informed consent was obtained from all of the participating subjects.
Detection of H. pylori infection. H. pylori infection status
was assessed by serology, histological examination, or the urea breath test. Patients were diagnosed as having infection when at least one of the diagnostic tests was positive.
Genotyping of polymorphisms. Polymorphism was genotyped by PCR-SSCP method as reported previously (22, 23) . To detect the IL-17A and -17F polymorphisms, using the primer pairs (IL-17AF, 5'-aacaagtaagaatgaaaagaggacatggt-3'; IL-17AR, 5'-cccccaatgaggtcatagaagaatc-3'; IL-17FF, 5'-gtgtag gaacttgggctgcatcaat-3'; and IL-17FR: 5'-agtggatatgcacctcttac tgcaca-3', respectively), one-tube multiplex PCR was carried out in a volume of 20 μl containing 0.1 μg of genomic DNA. The DNA was denatured at 96˚C for 90 sec, followed by 35 cycles at 96˚C for 15 sec, 58˚C for 30 sec, and 72˚C for 45 sec, with a final extension at 72˚C for 3 min. Thereafter, 2 μl of the PCR product was denatured with 10 μl of formamide (Sigma-Aldrich Co., St. Louis, USA) at 90˚C for 5 min. SSCP was carried out at 6 or 12˚C using a GenePhor DNA separation system with GeneGel Excel 12.5/24 (Amersham Biosciences Corp., USA), after which the denatured singlestrand DNA bands were detected using a DNA Silver Staining kit (Amersham Biosciences Corp.).
To detect MIF -794 CATT repeats and the G-173C polymorphism, using the primer pairs (MIFTRF, 5'-tgatcca gttgctgccttgtc-3'; MIFTRR, 5'-tccactaatggtaaactcggggac-3'; MIF173F, 5'-tctagccgccaagtggagaaca-3'; and MIF173R, 5'-act gtggtcccgccttttgtga-3', respectively), PCR was carried out in a volume of 20 μl containing 0.1 μg of genomic DNA. The DNA was denatured at 95˚C for 3 min, followed by 35 cycles at 95˚C for 30 sec, 60 or 62˚C for 40 sec, and 72˚C for 45 sec, with a final extension at 72˚C for 5 min. Thereafter, SSCP was carried out in a similar manner as described above.
Statistical analysis. Age data were expressed as the mean ± SD. Mean ages between 2 groups were compared with the Student's t-test. Allele and genotype frequencies were calculated by direct counting. The allele counts were compared by a 2x2 table using the Chi-square test. The strength of association between allele frequencies and the disease was assessed by calculating the odds ratio (OR) and 95% confidence intervals (CI) by logistic regression analysis using genotype as a variate or the number of alleles as a co-variate. Adjusted ORs were calculated with the use of logistic regression analysis after adjustment for age, gender and H. pylori infection status. The interaction between H. pylori infection and genotype was assessed by ANOVA using H. pylori infection status, gender and each genotype as variates. For all analyses, the level of significance was set at p<0.05.
Results
The characteristics of subjects and the frequencies of genotypes. As shown in Fig. 1 , single-strand DNAs of the IL-17A, -17F and MIF gene polymorphisms were clearly identified by SSCP. The characteristics of subjects and the frequencies of genotypes are shown in Table I . All genotypes were in Hardy-Weinberg equilibrium. The mean age of the non-symptom subjects was significantly lower than that of the dyspeptic subjects (Student's t-test; p<0.0001). The male/ female ratio was significantly higher in the former than in the latter by the Chi-square test (p=0.00035). There were no significant differences between H. pylori positivity and the frequencies of all genotypes between the two groups. Table I . Characteristics of the subjects and frequency of genotypes. 
FD, functional dyspepsia; EPS, epigastric pain syndrome; PDS, postprandial syndrome.
The association between functional dyspepsia and the IL-17A, -17F, and MIF gene polymorphisms. According to the unadjusted and adjusted analyses, female gender was significantly associated with the increased risk for FD (Tables II and III) . There was no significant relationship between FD and all genotypes of the IL-17A, -17F and MIF genes.
The association between the subgroups of functional dyspepsia and the IL-17A, -17F, and MIF gene polymorphisms.
Almost all of the genotypes of the IL-17A, -17F and MIF genes were not associated with the EPS and PDS subgroups (Table IV) . Only the MIF -173C allele carrier had a significantly increased risk for developing EPS, a subgroup of FD, by the unadjusted and adjusted analyses (OR, 2.11; 95% CI, 1.10-4.06; p=0.025, and OR, 2.12; 95% CI, 1.00-4.49; p=0.0497, respectively). Table III . Association between dyspepsia symptoms and MIF polymorphisms. 
a Adjustment for age, gender and H. pylori infection.
b Analyses were performed using the number of each allele as a co-variate. c p=0.0007.
- Table II . Association between dyspepsia symptoms and IL-17A -17F polymorphisms. - Table IV . Association between phenotypes of functional dyspepsia and IL-17A, -17F, MIF genotypes. 
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.98) -----------------------------------------------------------------------------------------------------a Adjustment for age, gender and H. pylori infection.
b Analyses were performed using the number of each allele as a co-variate. c p=0.025, d p=0.0497. ---------------------------------------------------------------------------------------------------------------- 
The association between the subgroups of functional dyspepsia and the IL-17A, -17F, and MIF gene polymorphisms in H. pylori-infected or -uninfected subjects.
When the interaction between the number of each allele and H. pylori infection to the development of FD was evaluated by ANOVA using H. pylori infection status, gender and the number of each allele as co-variates, we found that the number of IL-17F 7488T alleles was significantly associated with H. pylori infection in developing EPS (p=0.016). Therefore, we investigated the association between the subgroups of FD and genotypes in each H. pylori-positive or -negative case. As shown in Table V 
The interaction between H. pylori infection and genotype with inflammatory cell infiltration.
The mean values of the activity score and inflammation score of IL-17F and MIF genotypes in H. pylori-positive or -negative cases are shown in Table VI . Analyses were performed in 142 subjects (74 and 68 from the FD and non-symptom subjects, respectively). A significant interaction was observed between H. pylori infection and the IL-17F genotype with an increase in both the activity and inflammation scores (p=0.043 and p=0.042, respectively), whereas not between H. pylori infection and MIF genotypes. ---------------------------------------------------------------------------------------------------- 
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All analyses were performed after adjustment for age and gender. a p=0.032, b p=0.036, and c p=0.024.
- Table VI . The interaction between gene polymorphisms and H. pylori infection to inflammatory cell infiltration. 
The interaction was assessed by ANOVA using H. pylori infection status and genotype as variates.
Discussion
In the present study, we investigated the association of the IL-17A, -17F and MIF gene polymorphisms with FD and its subgroups. We found that IL-17F 7488T and MIF -173C alleles were significantly associated with an increased risk for EPS, a subgroup of FD, in H. pylori-infected subjects.
The precise pathophysiology of FD is unknown. A heterogeneous group of pathophysiologic mechanisms has been implicated in the etiology of FD. Delayed gastric emptying (24) , antral hypomotility (11), diminished gastric accommodation (25) , abnormal duodenal sensitivity to acid (26) , enhanced visceral sensitivity (27) , and psychological factors (28) have all been identified in subgroups of patients with FD, with much overlap. However, the relationship between inflammation and clinical presentation and the treatment response is not well established in FD, although histological inflammation has been implicated in the generation of gastrointestinal pain or discomfort (29) .
In the present study, we showed that MIF -173C allele carriers had a significantly increased risk for developing EPS, a subgroup of FD. In addition, the IL-17F 7488T allele, as well as the MIF -173C allele, were positively correlated with developing EPS in H. pylori-infected subjects. Several studies have shown that the -173C/-794 7-CATT haplotype is of importance in the susceptibility to inflammatory or immune disorders (18, 19, 30, 31) . With regard to the IL-17F polymorphism, Kawaguchi et al revealed that functional consequences of the H161R substitution were examined by using recombinant wild-type and mutant IL-17F proteins, and the expression and/or activity of IL-17F may be suppressed in IL-17F/7488C allele carriers (14) . Thus, both MIF -173C and IL-17F 7488T alleles seem to be associated with an increased risk for inflammation. These facts suggest that polymorphisms promoting inflammation are associated with EPS of FD under the influence of H. pylori infection. That is, gastric mucosal inflammation may affect the pathophysiology of certain subgroups of FD. During investigation of dyspepsia, three major structural causes are readily identifiable: peptic ulcer disease (10%), gastroesophageal refIux (20%) (with or without esophagitis) and malignancy (2%) (32) . This fact also suggests that one of the FD subgroup may be closely associated with gastric mucosal inflammation. It is well known that H. pylori plays a major role in the pathogenesis of gastroduodenal inflammation, including gastric and duodenal ulcers. Although H. pylori infection has been reported to be more frequent in patients with non-ulcer dyspepsia than control populations, the role of H. pylori infection in functional dyspepsia is still controversial (33 (36) . It was also reported that the abdominal pain score and indigestion score of the Gastrointestinal Symptoms Rating Scale are correlated with histological gastric mucosal atrophy and were significantly decreased after eradication therapy in H. pylori-infected patients with ulcer-like FD (37, 38) . Furthermore, Lamb et al demonstrated, using an experimental model, that gastric inflammation results in a hypersensitivity to chemical stimulation, including intraluminal acid, suggesting that sensitization to these stimulus modalities may contribute to the development of dyspeptic symptoms in patients with organic or functional diseases of the upper gastrointestinal tract (39). These facts indicate that H. pylori-induced gastric inflammation may produce the dyspeptic symptoms, including abdominal pain, via the up-regulating sensitivity to intraluminal acid. In our present study, a significant interaction was observed between the IL-17F 7488 and MIF -173 gene polymorphisms and H. pylori infection with the increase of neutrophil and mononuclear cell infiltration into the gastric mucosa. Therefore, we believe that the polymorphisms of the IL-17F and MIF genes affect epigastric pain in FD patients by the increased severity of H. pylori-induced gastric inflammation.
Recent evidence supports the relevance of a genetic milieu in FD. A case-control study by Holtmann et al suggested that there is a significant link between the GNß3 (C825T) CC genotype and functional dyspepsia (8) . This association was independently confirmed (9) . However, there are no reports suggesting the relationship between the polymorphisms of molecules associated with inflammation or immune response and FD. Depending on the population under study, between 30 and 65% of patients diagnosed with functional dyspepsia have H. pylori-induced gastritis (40, 41) . Our data also showed that the positivity of H. pylori infection in dyspeptic patients was 54%. Therefore, it is feasible that the polymorphisms of the genes associated with inflammation-or immune response-related molecules interact with H. pylori-induced gastric inflammation for the pathophysiology of one of the FD subgroup, although further studies will be necessary.
In conclusion, the IL-17F 7488T and MIF -173C alleles were significantly associated with the development of FD, particularly EPS, a subgroup of FD, in H. pylori-infected subjects. Our results provided the first evidence that the genetic polymorphisms of molecules associated with inflammation or immune response may be involved in the development of one of the FD subgroups via H. pyloriinduced gastric inflammation.
